Bacterial and Viral Skin Diseases

Dermatologic Clinics

Volumn 25, Issue 4, 2007, Pages 663-676

  Ruocco, Eleonora ^a   Donnarumma, Giovanna ^a   Baroni, Adone ^a   Tufano, Maria Antonietta ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CIDOFOVIR; FOSCARNET; GANCICLOVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BACTERIAL INFECTION; BACTERIAL SKIN DISEASE; CELLULAR IMMUNITY; HUMAN; IMMUNOCOMPETENCE; IMPETIGO; LABORATORY TEST; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOLLUSCUM CONTAGIOSUM; NEWBORN EXFOLIATIVE DERMATITIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES; SUBACUTE SCLEROSING PANENCEPHALITIS; TOXIC SHOCK SYNDROME; VIRAL SKIN DISEASE; VIRUS REPLICATION;

ANTI-BACTERIAL AGENTS; ANTIVIRAL AGENTS; HUMANS; SKIN DISEASES, BACTERIAL; SKIN DISEASES, VIRAL;

EID: 34548863331     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.det.2007.06.008     Document Type: Review

References (83)

1. Kazmierczak A.K., and Szewczyk E.M. Bacteria forming a resident flora of the skin as a potential source of opportunistic infections. Pol J Microbiol 53 4 (2004) 249-255
2. Hartmann A.A. The influence of various factors on the human resident skin flora. Semin Dermatol 9 4 (1990) 305-308
3. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 415 (2002) 389-395
4. Baroni A., Orlando M., Donnarumma G., et al. Toll-like receptor 2 (TLR2) mediates intracellular signalling in human keratinocytes in response to Malassezia furfur. Arch Dermatol Res 10 (2005) 1-9
5. Elsner P. Antimicrobials and the skin physiological and pathological flora. Curr Probl Dermatol 33 (2006) 35-41
6. Hoffler U., Gloor M., Peters G., et al. Qualitative and quantitative investigations on the resident bacterial skin flora in healthy persons and in the non-affected skin of patients with seborrheic eczema. Arch Dermatol Res 268 3 (1980) 297-312
7. Marina S.S., Bocheva G.S., and Kazanjieva J.S. Severe bacterial infections of the skin: uncommon presentations. Clin Dermatol 23 6 (2005) 621-629
8. Edlich R.F., Winters K.L., Britt L.D., et al. Bacterial diseases of the skin. J Long Term Eff Med Implants 15 5 (2005) 499-510
9. Akiyama H., Kanzaki H., Tada J., et al. Coagulase-negative staphylococci isolated from various skin lesions. J Dermatol 25 9 (1998) 563-568
10. Noble W.C. Skin bacteriology and the role of Staphylococcus aureus in infection. Br J Dermatol 139 Suppl 53 (1998) 9-12
11. Peacock S.J., de Silva I., and Lowy F.D. What determines nasal carriage of Staphylococcus aureus?. Trends Microbiol 9 (2001) 605-610
12. Lowy F.D. Staphylococcus aureus infections. N Engl J Med 339 (1998) 520-532
13. Foster T.J., and Hook M. Surface protein adhesins of Staphylococcus aureus. Trends Microbiol 6 (1998) 484-488
14. Skaar E.P., and Schneewind O. Iron-regulated surface determinants (Isd) of Staphylococcus aureus: stealing iron from heme. Microbes Infect 6 (2004) 390-397
15. O'Riordan K., and Lee J.C. Staphylococcus aureus capsular polysaccharides. Clin Microbiol Rev 17 (2004) 218-234
16. Schwarz-Linek U., Hook M., and Potts J.R. The molecular basis of fibronectin-mediated bacterial adherence to host cells. Mol Microbiol 52 (2004) 631-641
17. Schwarz-Linek U., Werner J.M., Pickford A.R., et al. Pathogenic bacteria attach to human fibronectin through a tandem β-zipper. Nature 423 (2003) 177-181
18. Dinges M.M., Orwin P.M., and Schlievert P.M. Exotoxins of Staphylococcus aureus. Clin Microbiol Rev 13 (2000) 16-34
19. Murray R.J. Recognition and management of Staphylococcus aureus toxin-mediated disease. Intern Med J 35 2 (2005) 106-119
20. Lina G., Gillet Y., Vandenesch F., et al. Toxin involvement in staphylococcal scalded skin syndrome. Clin Infect Dis 25 6 (1997) 1369-1373
21. Dondorp A.M., Veenstra J., van der Poll T., et al. Activation of the cytokine network in a patient with AIDS and the recalcitrant erythematous desquamating disorder. Clin Infect Dis 18 6 (1994) 942-945
22. Akiyama H., Morizane S., Yamasaki O., et al. Assessment of Streptococcus pyogenes microcolony formation in infected skin by confocal laser scanning microscopy. J Dermatol Sci 32 3 (2003) 193-199
23. Hirschmann J.V. Impetigo: etiology and therapy. Curr Clin Top Infect Dis 22 (2002) 42-51
24. Chiller K., Selkin B.A., and Murakawa G.J. Skin microflora and bacterial infections of the skin. J Investig Dermatol Symp Proc 6 3 (2001) 170-174
25. Akiyama H., Hamada T., Huh W.K., et al. Confocal laser scanning microscopic observation of glycocalyx production by Staphylococcus aureus in skin lesions of bullous impetigo, atopic dermatitis and pemphigus foliaceus. Br J Dermatol 148 3 (2003) 526-532
26. Travers J.B., Norris D.A., and Leung D.Y. The keratinocyte as a target for staphylococcal bacterial toxins. J Investig Dermatol Symp Proc 6 3 (2001) 225-230
27. Veien N.K. The clinician's choice of antibiotics in the treatment of bacterial skin infection. Br J Dermatol 139 53 (1998) 30-36
28. Thestrup-Pedersen K. Bacteria and the skin: clinical practice and therapy update. Br J Dermatol 139 53 (1998) 1-3
29. Bridge P.D., and Sneath P.H. Numerical taxonomy of Streptococcus. J Gen Microbiol 129 3 (1983) 565-597
30. Lawrence J., Yajko D.M., and Hadley W.K. Incidence and characterization of beta-hemolytic Streptococcus milleri and differentiation from S pyogenes (group A), S equisimilis (group C), and large-colony group G streptococci. J Clin Microbiol 22 5 (1985) 772-777
31. Schlievert P.M., Bohach G.A., Ohlendorf D.H., et al. Molecular structure of Staphylococcus and Streptococcus superantigens. J Clin Immunol 15 (1995) 4S-10S
32. Carlsson F., Sandin C., and Lindahl G. Human fibrinogen bound to Streptococcus pyogenes M protein inhibits complement deposition via the classical pathway. Mol Microbiol 56 1 (2005) 28-39
33. Cole J.N., McArthur J.D., McKay F.C., et al. Trigger for group A streptococcal M1T1 invasive disease. FASEB J 20 10 (2006) 1745-1747
34. Chatellier S., Ihendyane N., Kansal R.G., et al. Genetic relatedness and superantigen expression in group A streptococcus serotype M1 isolates from patients with severe and nonsevere invasive diseases. Infect Immun 68 6 (2000) 3523-3534
35. Courtney H.S., Hasty D.L., and Dale J.B. Anti-phagocytic mechanisms of Streptococcus pyogenes: binding of fibrinogen to M-related protein. Mol Microbiol 59 3 (2006) 936-947
36. Sandin C., Carlsson F., and Lindahl G. Binding of human plasma proteins to Streptococcus pyogenes M protein determines the location of opsonic and non-opsonic epitopes. Mol Microbiol 59 1 (2006) 20-30
37. Stevens D.L. Invasive group A streptococcal disease. Infect Agents Dis 5 3 (1996) 157-166
38. Kazmi S.U., Kansal R., Aziz R.K., et al. Reciprocal, temporal expression of SpeA and SpeB by invasive M1T1 group a streptococcal isolates in vivo. Infect Immun 69 8 (2001) 4988-4995
39. Baxter F., and McChesney J. Severe group A streptococcal infection and streptococcal toxic shock syndrome. Can J Anaesth 47 11 (2000) 1129-1140
40. Everest E. Group A streptococcal fasciitis. Crit Care Resusc 1 1 (1999) 63-68
41. Crum N.F., and Wallace M.R. Group B streptococcal necrotizing fasciitis and toxic shock-like syndrome: a case report and review of the literature. Scand J Infect Dis 35 11-12 (2003) 878-881
42. Currie B.J. Group A streptococcal infections of the skin: molecular advances but limited therapeutic progress. Curr Opin Infect Dis 19 2 (2006) 132-138
43. Kazmierczak A.K., Szarapinska-Kwaszewska J.K., and Szewczyk E.M. Opportunistic coryneform organisms residents of human skin. Pol J Microbiol 54 1 (2005) 27-35
44. Golledge C.L., and Phillips G. Corynebacterium minutissimum infection. J Infect 23 1 (1991) 73-76
45. Holdiness M.R. Management of cutaneous erythrasma. Drugs 62 8 (2002) 1131-1141
46. Funke G., von Graevenitz A., Clarridge III J.E., et al. Clinical microbiology of coryneform bacteria. Clin Microbiol Rev 10 1 (1997) 125-159
47. Connell T.G., Rele M., Daley A.J., et al. Skin ulcers in a returned traveller. Lancet 365 (2005) 19-25
48. von Hunolstein C., Alfarone G., Scopetti F., et al. Molecular epidemiology and characteristics of Corynebacterium diphtheriae and Corynebacterium ulcerans strains isolated in Italy during the 1990s. J Med Microbiol 52 2 (2003) 181-188
49. Do T.T., Strub W.M., and Witte D. Subacute Propionibacterium acnes osteomyelitis of the spine in an adolescent. J Pediatr Orthop B 12 4 (2003) 284-287
50. Pan S.C., Wang J.T., Hsueh P.R., et al. Endocarditis caused by Propionibacterium acnes: an easily ignored pathogen. J Infect 51 4 (2005) 229-231
51. Oprica C., and Nord C.E. ESCMID Study Group on Antimicrobial Resistance in Anaerobic Bacteria. European surveillance study on the antibiotic susceptibility of Propionibacterium acnes. Clin Microbiol Infect 11 3 (2005) 204-213
52. Tariq S., Hameed S., Tyrer M., et al. Pseudomonal sepsis with subcutaneous nodules in an HIV-infected individual with high CD4 counts. J Infect 51 5 (2005) 419-420
53. Jones M.E., Karlowsky J.A., Draghi D.C., et al. Epidemiology and antibiotic susceptibility of bacteria causing skin and soft tissue infections in the USA and Europe: a guide to appropriate antimicrobial therapy. Int J Antimicrob Agents 22 4 (2003) 406-419
54. Grieco T., Cantisani C., Innocenzi D., et al. Acute generalized exanthematous pustulosis caused by piperacillin/tazobactam. J Am Acad Dermatol 52 4 (2005) 732-733
55. Street M.L., Umbert-Miller I.J., Roberts G.D., et al. Nontuberculous mycobacterial infections of the skin. Report of fourteen cases and review of the literature. J Am Acad Dermatol 24 (1991) 208-215
56. Ena P., Sechi L.A., Saccabusi S., et al. Rapid identification of cutaneous infections by nontubercular mycobacteria by polymerase chain reaction-restriction analysis length polymorphism of the hsp65 gene. Int J Dermatol 40 (2001) 495-499
57. van der Werf T.S., Stienstra Y., Johnson R.C., et al. Mycobacterium ulcerans disease. Bull World Health Organ 83 10 (2005) 785-791
58. Ang P., Rattana-Apiromyakij N., and Goh C.L. Retrospective study of Mycobacterium marinum skin infections. Int J Dermatol 39 (2000) 343-347
59. Ho M.H., Ho C.K., and Chong L.Y. Atypical mycobacterial cutaneous infections in Hong Kong: 10-year retrospective study. Hong Kong Med J 12 1 (2006) 21-26
60. Park K.C., and Han W.S. Viral skin infections: diagnosis and treatment considerations. Drugs 62 3 (2002) 479-490
61. Haas S., Park T.W., Voigt E., et al. Detection of HPV 52, 58 and 87 in cervicovaginal intraepithelial lesions of HIV infected women. Int J Mol Med 16 5 (2005) 815-819
62. Akgul B., Cooke J.C., and Storey A. HPV-associated skin disease. J Pathol 208 2 (2006) 165-175
63. Ortak T., Uysal A.C., Alagoz M.S., et al. Epidermodysplasia verruciformis: an unusual presentation. Dermatol Surg 32 2 (2006) 302-306
64. Giovannelli L., Lama A., Capra G., et al. Detection of human papillomavirus DNA in cervical samples: analysis of the new PGMY-PCR compared to the hybrid capture II and MY-PCR assays and a two-step nested PCR assay. J Clin Microbiol 42 8 (2004) 3861-3864
65. Purdie K.J., Surentheran T., Sterling J.C., et al. Human papillomavirus gene expression in cutaneous squamous cell carcinomas from immunosuppressed and immunocompetent individuals. J Invest Dermatol 125 1 (2005) 98-107
66. Looker K.J., and Garnett G.P. A systematic review of the epidemiology and interaction of herpes simplex virus types 1 and 2. Sex Transm Infect 81 2 (2005) 103-107
67. Lafferty W.E., Downey L., Celum C., et al. Herpes simplex virus type 1 as a cause of genital herpes: impact on surveillance and prevention. J Infect Dis 181 (2000) 1454-1457
68. Lowhagen G.B., Tunback P., and Bergstrom T. Proportion of herpes simplex virus (HSV) type 1 and type 2 among genital and extragenital HSV isolates. Acta Derm Venereol 82 (2002) 118-120
69. David W.K. Neonatal herpes simplex infection. Clin Microbiol Rev 17 1 (2004) 1-13
70. Hanson D., and Diven D.G. Molluscum contagiosum. Dermatol Online J 9 2 (2003) 2
71. Yanagi Y., Takeda M., Ohno S., et al. Measles virus receptors and tropism. Jpn J Infect Dis 59 1 (2006) 1-5
72. Kuhne Simmonds M., Jin L., and Brown D.W. Measles viral load may reflect SSPE disease progression. Virol J 3 1 (2006) 49
73. Friederichs V., Cameron J.C., and Robertson C. Impact of adverse publicity on MMR vaccine uptake: a population based analysis of vaccine uptake records for one million children, born 1987-2004. Arch Dis Child 91 6 (2006) 465-468
74. Murphy FA, Fauquet CM, Bishop DHL, et al. In: Virus taxonomy, 6th report of the International Committee on Taxonomy of Viruses (ICTV). Arch Virol 1995;10:1-586.
75. Wilson K.M., Di Camillo C., Doughty L., et al. Humoral immune response to primary rubella virus infection. Clin Vaccine Immunol 13 3 (2006) 380-386
76. Young N.S., and Brown K.E. Parvovirus B19. N Engl J Med 350 (2004) 586-597
77. Sanabani S., Neto WK Pereira J., and Sabino E.C. Sequence variability of human erythroviruses present in bone marrow of Brazilian patients with various Parvovirus B19-related hematological symptoms. J Clin Microbiol 44 2 (2006) 604-607
78. Yoto Y., Qiu J., and Pintel D.J. Identification and characterization of two internal cleavage and polyadenylation sites of Parvovirus B19 RNA. J Virol 80 3 (2006) 1604-1609
79. Abdel-Haq N.M., and Asmar B.I. Human Herpes Virus 6 (HHV6) infection. Indian J Pediatr 71 1 (2004) 89-96
80. Yoshida M., Yamada M., Tsukazaki T., et al. Comparison of antiviral compounds against human herpes virus 6 and 7. Antiviral Res 40 1-2 (1998) 73-84
81. Ku C.C., Besser J., Abendroth A., et al. Varicella-Zoster virus pathogenesis and immunobiology: new concepts emerging from investigations with the SCIDhu Mouse Model. J Virol 79 5 (2005) 2651-2658
82. Bosnjak L., Jones C.A., Abendroth A., et al. Dendritic cell biology in herpesvirus infections. Viral Immunol 18 3 (2005) 419-433
83. Holten K.B. Treatment of herpes zoster. Am Fam Physician 73 5 (2006) 882-884